(Q34295241)

1 August 2017

Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo (English)

1 reference

1 August 2017

1 reference

Jonathan A Ewald

1

1 reference

1 August 2017

Joshua A Desotelle

2

1 reference

1 August 2017

Dawn R Church

3

1 reference

1 August 2017

Bing Yang

4

1 reference

1 August 2017

Wei Huang

5

1 reference

1 August 2017

Timo A Laurila

6

1 reference

1 August 2017

David F Jarrard

7

1 reference

1 August 2017

21 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

73

1 reference

1 August 2017

4

1 reference

1 August 2017

337-345

1 reference

Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Therapy-induced senescence in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Cellular senescence predicts treatment outcome in metastasised colorectal cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Pseudo-DNA damage response in senescent cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Heterochromatin and its relationship to cell senescence and cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

CellProfiler: free, versatile software for automated biological image analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Senescence-associated beta-galactosidase is lysosomal beta-galactosidase

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Tumor cell senescence in cancer treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Cellular senescence as a tumor-suppressor mechanism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

p27KIP1: androgen regulation and prognostic significance in prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Tumor suppressors and oncogenes in cellular senescence.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Quantitative assessment of markers for cell senescence.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPROS.22571

Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPROS.22571

Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4753826

Programmed Cell Death (Apoptosis) and Cancer Chemotherapy

28 October 2018

1 reference

12 December 2020

Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograft

1 reference

12 December 2020

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

1 reference

12 December 2020

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy

1 reference

12 December 2020

Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence

1 reference

12 December 2020

Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma

1 reference

12 December 2020

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells

1 reference

12 December 2020

Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study

1 reference

12 December 2020

Identifiers

DOI

10.1002/PROS.22571

1 reference

1 August 2017

1 reference

1 August 2017

1 reference